Bank of America Raises PO On Seattle Genetics To $19

August 30, 2011 6:14 AM | 8 seconds read | Make a Comment

Bank of America has raised the price objective on Seattle Genetics

SGEN

from $17 to $19 and maintains its Buy rating.

Posted In: Price Target Analyst Ratings Bank of America Biotechnology Health Care

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.